ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.


Player Avatar 78taxs (< 20) Submitted: 12/22/2012 10:43:27 PM : Outperform Start Price: $1.57 ACAD Score: +388.31

This will go a long way to help the nervous that some ones need.

Featured Broker Partners